Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Tomer Meirson"'
Autor:
Tomer Meirson, Valerio Nardone, Francesca Pentimalli, Gal Markel, David Bomze, Maria D’Apolito, Pierpaolo Correale, Antonio Giordano, Luigi Pirtoli, Camillo Porta, Steven G Gray, Luciano Mutti
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract In this commentary, using existing clinical trial data and FDA approvals we propose that there is currently a critical need for an appropriate balancing between the financial impact of new cancer drugs and their actual benefit for patients.
Externí odkaz:
https://doaj.org/article/31b55a1ccc204e26bbba66e8945e4d5e
Autor:
Tom Domovitz, Samer Ayoub, Michal Werbner, Joel Alter, Lee Izhaki Tavor, Yfat Yahalom-Ronen, Evgeny Tikhonov, Tomer Meirson, Yaakov Maman, Nir Paran, Tomer Israely, Moshe Dessau, Meital Gal-Tanamy
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Recent studies suggest the enhancement of liver injury in COVID-19 patients infected with Hepatitis C virus (HCV). Hepatocytes express low levels of angiotensin-converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor, raising the possibili
Externí odkaz:
https://doaj.org/article/7a83e1314cde4b69ba8f3d17ef7f1be6
Autor:
Ithai Waldhorn, Ayelet Dekel, Anna Morozov, Elisa Sardas Alon, Danielle Stave, Noam Ben Tsrooya, Shir Schlosser, Gal Markel, David Bomze, Tomer Meirson
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
It has been widely reported that women are underrepresented in leadership positions within academic medicine. This study aimed to assess trends in women representation as principal investigators (PIs) in oncology clinical trials and to characterize t
Externí odkaz:
https://doaj.org/article/44ef13383e4847149b4c5c2fd8bd990a
Autor:
Ronnie Shapira-Frommer, Elad Jacoby, Orit Itzhaki, Abraham Nissani, Gal Markel, Jacob Schachter, Shaked Lev-Ari, Tomer Meirson, Nethanel Asher, Guy Ben-Betzalel, Michal J. Besser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Adoptive cell therapy with T cells genetically engineered to express a chimeric antigen receptor (CAR-T) or tumor-infiltrating T lymphocytes (TIL) demonstrates impressive clinical results in patients with cancer. Lymphodepleting preconditi
Externí odkaz:
https://doaj.org/article/b123a9cc796845809ac8adf818ec97d0
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Autor:
Shira Perez, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat Lavi-Itzkovitz, Tomer Meirson, Jacinta Alison Holmes, Chia-Yen Dai, Chung-Feng Huang, Raymond T Chung, Assy Nimer, Assam El-Osta, Gur Yaari, Salomon M Stemmer, Ming-Lung Yu, Izhak Haviv, Meital Gal-Tanamy
Publikováno v:
PLoS Genetics, Vol 15, Iss 6, p e1008181 (2019)
The increasing worldwide prevalence of Hepatocellular carcinoma (HCC), characterized by resistance to conventional chemotherapy, poor prognosis and eventually mortality, place it as a prime target for new modes of prevention and treatment. Hepatitis
Externí odkaz:
https://doaj.org/article/5d55b573e1f747e1963ba5aa57bd0af9
Publikováno v:
PLoS Computational Biology, Vol 12, Iss 12, p e1005293 (2016)
Accurate prediction of active sites is an important tool in bioinformatics. Here we present an improved structure based technique to expose active sites that is based on large changes of solvent accessibility accompanying normal mode dynamics. The te
Externí odkaz:
https://doaj.org/article/569bebde27f14bf0968d393fe42e326d
Autor:
Liat Ninio, Abraham Nissani, Tomer Meirson, Tom Domovitz, Alessandro Genna, Shams Twafra, Kolluru D. Srikanth, Roba Dabour, Erez Avraham, Ateret Davidovich, Hava Gil-Henn, Meital Gal-Tanamy
Publikováno v:
Cells, Vol 8, Iss 11, p 1395 (2019)
Hepatocellular carcinoma (HCC) represents the fifth most common cancer worldwide and the third cause of cancer-related mortality. Hepatitis C virus (HCV) is the leading cause of chronic hepatitis, which often results in liver fibrosis, cirrhosis, and
Externí odkaz:
https://doaj.org/article/2116a9b99f8f4498835802f3524446f8
Publikováno v:
The Lancet Oncology. 24:589-593
Publikováno v:
Journal of Clinical Oncology. 41:2713-2717
Publikováno v:
Hepatobiliary Surgery and Nutrition. 12:272-275